Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials

• Christine M. Lovly ,

  Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Kimberly Brown Dahlman ,

  Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su

  Affiliation Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Laurel E. Fohn ,

  Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Zengliu Su ,

  Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Dora Dias-Santagata,

  Affiliation Translational Research Laboratory, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Donna J. Hicks,

  Affiliation Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Donald Hucks,

  Affiliation Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Elizabeth Berry,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Charles Terry,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• MarKeesa Duke,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Yingjun Su,

  Affiliation Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Tammy Sobolik-Delmaire,

  Affiliation Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Ann Richmond,

  Affiliation Department of Cancer Biology, Department of Veterans Affairs, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Mark C. Kelley,

  Affiliation Division of Surgical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Cindy L. Vnencak-Jones,

  Affiliation Departments of Pathology, Microbiology, Immunology and Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• A. John Iafrate,

  Affiliation Translational Research Laboratory, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jeffrey Sosman ,

  ¶These senior authors also contributed equally to this work.

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
•  [ ... ],
• William Pao

  * E-mail: william.pao@vanderbilt.edu

  Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• [ view all ]
• [ view less ]